Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Accounts Receivable
The a/r for Labcorp Holdings Inc. (LH) is $2.26 Billion with a year-over-year change of +7.81%. Accounts Receivable (A/R) represents money owed to the company by customers for goods or services delivered but not yet paid for.
LH A/R Chart
LH A/R
$2.26B+358.19% 20Y
Zoom
Current A/R
$2.26B
$2.26 Billion
Year-over-Year Change
+7.81%
vs. $2.10B prior year
Historical Data
30
Years of data available
Annual A/R History
| Year | A/R | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.26B | +$163.70M | +7.81% |
| 2024 | $2.10B | $-1.70M | -0.08% |
| 2023 | $2.10B | +$101.40M | +5.08% |
| 2022 | $2.00B | $-981.00M | -32.94% |
| 2021 | $2.98B | $-38.30M | -1.27% |
| 2020 | $3.02B | +$991.30M | +48.95% |
| 2019 | $2.03B | +$163.00M | +8.75% |
| 2018 | $1.86B | +$14.80M | +0.80% |
| 2017 | $1.85B | +$328.80M | +21.65% |
| 2016 | $1.52B | +$144.20M | +10.49% |
| 2015 | $1.37B | +$558.80M | +68.51% |
| 2014 | $815.70M | +$31.00M | +3.95% |
| 2013 | $784.70M | +$66.20M | +9.21% |
| 2012 | $718.50M | +$18.70M | +2.67% |
| 2011 | $699.80M | +$44.20M | +6.74% |
| 2010 | $655.60M | +$81.40M | +14.18% |
| 2009 | $574.20M | $-57.40M | -9.09% |
| 2008 | $631.60M | +$8.40M | +1.35% |
| 2007 | $623.20M | +$81.90M | +15.13% |
| 2006 | $541.30M | +$47.90M | +9.71% |
| 2005 | $493.40M | +$52.00M | +11.78% |
| 2004 | $441.40M | +$8.90M | +2.06% |
| 2003 | $432.50M | +$39.50M | +10.05% |
| 2002 | $393.00M | +$27.50M | +7.52% |
| 2001 | $365.50M | $-2.50M | -0.68% |
| 2000 | $368.00M | +$20.00M | +5.75% |
| 1999 | $348.00M | $-27.40M | -7.30% |
| 1998 | $375.40M | +$44.80M | +13.55% |
| 1997 | $330.60M | $-175.00M | -34.61% |
| 1996 | $505.60M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter